AzTrials
AzTrials

Cervical Radicular PainNCT07825545

Patient Reported Recovery of Muscle Strength After Surgery for Cervical Radiculopathy, Impact of Duration and Severity on Recovery.

An observational study of Cervical Radicular Pain and Spondylosis, Cervical, run by University Hospital of North Norway at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

DCR surgery is generally recommended for patients with severe or progressive limb paresis. The incidence of motor weakness reported to be up to 70%, with a varying recovery rate up to 90%, and the prospects of recovery is most likely dependent on paresis severity and duration. Read more about this study

Who is it for?
Ages 16 years and older
What is being tested?
Anterior cervical discetomi and fusion/posterior decompression
Type of treatment
Surgery or procedure
How many people
2,000 participants
Where
1 siteNorway
Study dates
1 Jan 2012to 31 Dec 2023
How long will I take part?
12 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The study will include consecutive patients operated for DCR and registered in NORspine form January 2012 through 2022, approximately 12.000 cases. Patients operated for cervical myelopathy will be excluded. Otherwise patients under the age of 16, those operated for fractures, tumours and primary infections, as well as those unable to give informed consent, are not included in the NORspine.

Who may be able to join

  • Surgery due to degenerative cervical radiculopathy with a preoperative muscle weakness
  • Posterior and anterior approach (ACDF/artificial disc replacement, posterior foramenotomi)

Who cannot join

  • Myelopathy as surgical indication
  • Tumor as surgical indication
  • Infection as surgical indication
  • Fracture as surgcial indication
  • Posterior fusion and laminectomy
  • Prior cervical surgery
  • Anterior corpectomy

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Neurosurgical department, University Hospital of North Norway

    Tromsø, 9010

Other trials in Norway

About this study

Official title: Patient Reported Recovery of Muscle Strength After Surgery for Cervical Radiculopathy, Impact of Duration and Severity on Recovery. A Population Based Study by NOrspine

DCR surgery is generally recommended for patients with severe or progressive limb paresis. The incidence of motor weakness reported to be up to 70%, with a varying recovery rate up to 90%, and the prospects of recovery is most likely dependent on paresis severity and duration. Operative treatment could facilitate earlier recovery, but the evidence is weak and based on smaller and heterogeneous DCM/DCR populations. There is also a lack of knowledge concerning timing of surgery, i.e. the influence of paresis duration, surgical delay and preoperative paresis. It is also unclear if there is an association between the underlying DCR pathology (disc herniation, spondylosis or both) and prognosis. The aim of this sub-study is to assess the frequency and severity of limb preoperative paresis in patients operated for DCR, and to improve prognostication of recovery and timing of surgery. To the best of our knowledge, these issues have not been properly investigated previously.

New knowledge in this field is highly sought by clinicians and can Inform patients, and physicians in shared decision making, i.e. helping them to choose more wisely between different treatment strategies. New insight in this field would be also be useful in clinical guideline development, for reducing surgical practice variation, for modifying outcome expectations, improve patient selection (clinical guideline development) and clinical outcomes of DCR surgery.

Read the detailed description

The most common cause of cervical operation is Degenerative cervical radiculopathy (DCR), i.e. a neural impingement by disc herniation or spondylotic changes. While pain is often the most prevalent indication of surgery, motor weakness is frequently reported and is associated with less favourable outcome.

Preoperative motor weakness is reported up to 70%. Some studies suggest that both the severity and duration of preoperative motor weakness are associated with persistent postoperative weakness, implying that delayed intervention may reduce the likelihood of full neurological recovery.

Moreover, current evidence does not establish whether surgery is preferable to conservative treatment in patients with motor weakness. The optimal timing of surgery and the grades of weakness most likely to benefit also remain unclear. A systematic review was unable to draw firm conclusions because studies varied substantially in strength assessment methods, outcome definitions, and follow-up duration.

Thomé et al. reported that, in lumbar radiculopathy, the association between early surgery and motor recovery was dependent on both baseline muscle grade and symptom duration.12 However, these findings may not be generalisable to cervical radiculopathy given key anatomical and pathological differences.

This study aims to evaluate the association between the preoperative duration and baseline severity (muscle strength grade) of motor weakness and complete strength recovery at 12 months after surgery for DCR. As a secondary, exploratory aim, we will assess whether there is a severity grade and/or duration window in which the probability of complete recovery is highest.

Primary Objective Evaluate the association of (1) patient-reported duration of weakness prior to surgery (timing proxy) and (2) baseline objective motor deficit severity (MRC grade) with patient-reported complete strength recovery (Yes/No) at 12 months following single-level surgery for cervical radiculopathy.

Exploratory objectives

  • Identify candidate cut points for timing and/or baseline MRC using tree-based recursive partitioning to predict 12-month complete recovery (cervical-specific threshold discovery).
  • Evaluate predictive discrimination using ROC/AUC for timing, MRC, and combined models (with internal validation if feasible).

Secondary Objectives

  • Assess effect modification (Timing × MRC interaction) for the primary endpoint.
  • Evaluate associations of timing and baseline MRC with NDI and NRS outcomes (arm pain, neck pain, headache) at 12 months (and at 3 months if available). -Evaluate postoperative strength trajectory using a binary outcome measure complete recovery (yes/no) at 3 and 12 months with random effects (Thomé-analogue trajectory analysis under registry constraints).
  • Perform etiology-stratified subgroup analyses (disc herniation vs spondylotic foraminal stenosis) to assess heterogeneity of associations.

Hypothesis Our null hypothesis is that the prognosis of recovery for DCR patients with paresis is independent of paresis severity, duration and underlying pathology. Our alternative hypothesis is that the recovery rate of paresis after DCR surgery is less for more severe paresis of longer duration and will vary according to underlying pathology.

Study populations The study will include consecutive patients operated for DCR and registered in NORspine form January 2012 through 2022, approximately 12.000 cases. Patients operated for cervical myelopathy will be excluded. Otherwise patients under the age of 16, those operated for fractures, tumours and primary infections, as well as those unable to give informed consent, are not included in the NORspine.

Data sources The project will use prospectively collected data from The Norwegian registry for spine surgery NORspine as the only data source, The NORspine is a comprehensive national clinical registry, with a capture rate of patients operated for DCR of 80% from in 2021 and a response rate at one year follow up (2022) of 80%. Coverage at the institutional level is 95-100%. A wide range of established and possible prognostic factors are recorded in the NORspine prior to surgery. Patient reported outcome measures (PROMs), are recorded at admission for surgery (baseline) and 3 and 12 months (maximum follow up time) after surgery.

Predictors / Exposure Variables

-Timing proxy: patient-reported weakness duration prior to surgery (registry item; English translation) Baseline question: "Do you have reduced strength (weakness) in the affected shoulder, arm, or hand?" (Yes/No).

If Yes: duration (choose one; optional numeric field where available):

  • Less than 24 hours (optional: number of hours)
  • Less than one week (optional: number of days)
  • 1 week to 3 months (optional: number of weeks)
  • 3 months to 12 months
  • More than 12 months

Operationalization (prespecified):

  • Primary: derive duration in days when numeric detail is available (hours/days/weeks converted to days).
  • Otherwise: treat duration as an ordered categorical predictor using the registry intervals.
  • Sensitivity: apply a prespecified category-to-days mapping (e.g., midpoint assumptions) when numeric detail is missing; assumptions reported explicitly.

Baseline objective motor deficit severity (MRC) Preoperative MRC grade (0-5) recorded by clinician/surgeon for a prespecified key muscle group corresponding to the index level, according to the institution's standard mapping. The cohort is restricted to objective weakness at baseline (MRC < 5).

Planned MRC coding (depending on data)

  • Primary coding: severe 0-2 /moderate 3 / mild 4
  • Secondary coding: severe ≤3 vs non-severe ≥4. Note: Tree-based methods may identify alternative splits; these will be reported as exploratory and will not redefine confirmatory coding.

Covariates / confounding control Potential confounders/covariates will be evaluated a priori based on clinical knowledge and registry availability by directed acyclic graph (DAG). Adjusted models will be specified before analysis and will not rely on automated or purely significance-driven variable selection.

Statistical Analysis Plan

Primary Confirmatory Analysis (Prediction of 12-month complete recovery)

  • Outcome: complete recovery at 12 months (Yes/No).
  • Model: multivariable logistic regression.
  • Key predictors: weakness duration (days with non-linearity assessment; otherwise ordinal categories) and baseline MRC severity (0-3 vs 4; secondary 0-2/3/4 if feasible).
  • Confounding control: covariates will be evaluated and specified a priori; models will not rely on automated or purely significance-driven variable selection.
  • Effect modification: prespecified duration × MRC interaction; etiology interaction and/or stratified reporting.

Secondary Trajectory Analysis (binary longitudinal strength outcome at 3 and 12 months)

  • Outcome: Complete recovery (yes/no) or complete or improved recovery (yes/no) status at 3 and 12 months
  • Model: logistic mixed-effects model with patient random intercept and fixed effect of time (12 vs 3 months), plus baseline predictors and prespecified interactions.

Exploratory Threshold Discovery (Tree-based)

  • Conditional inference tree / recursive partitioning to identify candidate cervical-specific cut points in duration and/or baseline MRC predicting 12-month complete recovery.
  • Internal validation via cross-validation and/or bootstrap where feasible.
  • Tree-based methods are used only for exploratory threshold discovery and will not be used for confounder selection.

Exploratory Discrimination (ROC/AUC)

•ROC/AUC for models using (a) timing alone, (b) MRC alone, and (c) combined predictors, with internal validation if feasible.

Missing Data

  • Describe extent/patterns of missingness in predictors and outcomes.
  • Primary analysis: complete-case for required 12-month outcome; sensitivity analyses as appropriate.
  • Longitudinal models incorporate partially observed 3/12-month outcomes under MAR conditional on observed covariates and earlier outcomes; sensitivity analyses may include inverse probability weighting and/or multiple imputation.
Being tested
Anterior cervical discetomi and fusion/posterior decompression
Medical subject headings
Spondylosis, Muscle Weakness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anterior cervical discetomi and fusion/posterior decompressionProcedure or surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. patient reported improvement of paresis (complete)

    Follow-up strength question (3 and 12 months): "If you had reduced strength (weakness) in your shoulder/arm/hand before the operation-has this changed?"

    Response options:

    • Has become completely normal
    • Has improved
    • Unchanged
    • Has worsened

    Primary endpoint derivation (12 months):

    • Complete recovery = Yes: "Has become completely normal".
    • Complete recovery = No: all other responses.

    Measured: 12 month

Secondary outcomes (7)
  1. Neck disability index (NDI)

    Neck disability index (NDI) is a measure of neck pain related disability, containing 10 items (pain, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation), all scored on a 6-point ordinal scale (0-5). The 10 items are summarized and recalculated to a percentage score ranging from 0 to 100 (no to maximum disability). Change from baseline to 12 month follow up will be computed. NDI change will be dichotomized to success yes/no as 35% improvement

    Measured: 12 month

  2. EuroQol-5D (EQ5D)

    EuroQoL (EQ-5D-3L) is a generic measurement and preference-weighted measure of health-related quality-of- life based on five dimensions: mobility, self-care, usual activity, pain/discomfort and anxiety/discomfort. For each dimension the patient assesses three possible levels (3L) of problems; "none," "mild to moderate," and "severe." The score ranges from 0.59 to 1, where 1 corresponds to perfect health and 0 to death and negative values worse than death. In the second part, called the EQ-VAS, the patient is asked to indicate overall health on a vertical analogue scale, ranging from 0 to 100 ("worst to "best imaginable health").

    Measured: 12 month

  3. Patient and surgeon reported complications

    intra and post operativ complications

    Measured: 12 month

  4. NRS head

    Numeric Rating Scale for Headache (NRS-HA) assesses pain severity ranging from 0 to 10 ("no" to "worst conceivable pain"). Change from baseline to 12 month follow up will be computed.

    Measured: 12 month

  5. NRS neck

    Numeric Rating Scale for neck (NRS-NE) assesses pain severity ranging from 0 to 10 ("no" to "worst conceivable pain"). Change from baseline to 12 month follow up will be computed.

    Measured: 12 month

  6. NRS head

    Numeric Rating Scale for arm (NRS-AR) assesses pain severity ranging from 0 to 10 ("no" to "worst conceivable pain"). Change from baseline to 12 month follow up will be computed.

    Measured: 12 month

  7. Improved or complete recovery

    Follow-up strength question (3 and 12 months): "If you had reduced strength (weakness) in your shoulder/arm/hand before the operation-has this changed?"

    Response options:

    • Has become completely normal
    • Has improved
    • Unchanged
    • Has worsened
    • Binary outcome improvement (yes/no) at 3 and 12 months: yes (Has become completely normal and Has improved) and no (Unchanged and Has worsened)

    Measured: 12 and 3 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2026
  2. Study start1 Jan 2012
  3. Primary completion31 Dec 2023
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
2,000 participants (actual)
Target duration
12 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT07825545
Sponsor's protocol ID
03276-2
Status last verified
Sep 2026
First submitted
13 Sep 2026
Last updated
17 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Do to norwegian privacy and research laws

Publications

  • Thome C, Kogl N, Grassner L, Vo AK, Kramer JLK, Petr O. Motor Recovery Depends on Timing of Surgery in Patients With Lumbar Disk Herniation. Neurosurgery. 2022 Mar 1;90(3):347-353. doi: 10.1227/NEU.0000000000001825. Epub 2022 Jan 17.

    PubMed 35040807
  • Gebreyohanes A, Erotocritou M, Choi D. Appraising The Evidence for Conservative versus Surgical Management of Motor Deficits in Degenerative Cervical Radiculopathy. Global Spine J. 2023 Mar;13(2):547-562. doi: 10.1177/21925682221109562. Epub 2022 Jun 16.

    PubMed 35708971
  • Burneikiene S, Nelson EL, Mason A, Rajpal S, Villavicencio AT. The duration of symptoms and clinical outcomes in patients undergoing anterior cervical discectomy and fusion for degenerative disc disease and radiculopathy. Spine J. 2015 Mar 1;15(3):427-32. doi: 10.1016/j.spinee.2014.09.017. Epub 2014 Sep 28.

    PubMed 25264315
  • Sebastian AS, Wagner S, Butler JS, Morrissey P, Kaye ID, Kepler CK. Wednesday, September 26, 2018 7:35 AM&#x2013;9:00 AM ePosters: P101. Favorable prognosis for significant preoperative upper extremity weakness following elective anterior cervical discectomy and fusion. The Spine Journal. 2018;18(8):S187. doi:10.1016/j.spinee.2018.06.639

  • Mazmudar A, Hopkins B, Hsu WK, Patel AA. 171. Postoperative recovery of motor strength and patient-reported physical function following anterior cervical discectomy and fusion. The Spine Journal. 2019/09/01/ 2019;19(9, Supplement):S83. doi:https://doi.org/10.1016/j.spinee.2019.05.188

  • Kreitz T, Huang R, Beck D, Park AG, Hilibrand A. Prolonged Preoperative Weakness Affects Recovery of Motor Function After Anterior Cervical Diskectomy and Fusion. J Am Acad Orthop Surg. 2018 Jan 15;26(2):67-73. doi: 10.5435/JAAOS-D-16-00606.

    PubMed 29239868
  • Hamburger C, Festenberg FV, Uhl E. Ventral discectomy with pmma interbody fusion for cervical disc disease: long-term results in 249 patients. Spine (Phila Pa 1976). 2001 Feb 1;26(3):249-55. doi: 10.1097/00007632-200102010-00009.

    PubMed 11224860
  • Lehmann CL, Buchowski JM, Stoker GE, Riew KD. Neurologic recovery after anterior cervical discectomy and fusion. Global Spine J. 2014 Feb;4(1):41-6. doi: 10.1055/s-0033-1360723. Epub 2013 Nov 15.

    PubMed 24494180
  • Lee U, Kim CH, Chung CK, Choi Y, Yang SH, Park SB, Hwang SH, Jung JM, Kim KT. The Recovery of Motor Strength after Posterior Percutaneous Endoscopic Cervical Foraminotomy and Discectomy. World Neurosurg. 2018 Jul;115:e532-e538. doi: 10.1016/j.wneu.2018.04.090. Epub 2018 Apr 22.

    PubMed 29689395
  • Kaiser MG, Haid RW, Shaffrey CI, Fehlings MG. Degenerative Cervical Myelopathy and Radiculopathy: Treatment Approaches and Options. Cham: Springer International Publishing AG; 2019.

  • Kristiansen JA, Balteskard L, Slettebo H, Nygaard OP, Lied B, Kolstad F, Solberg TK. The use of surgery for cervical degenerative disease in Norway in the period 2008-2014 : A population-based study of 6511 procedures. Acta Neurochir (Wien). 2016 May;158(5):969-74. doi: 10.1007/s00701-016-2760-1. Epub 2016 Mar 17.

    PubMed 26983821
  • Radhakrishnan K, Litchy WJ, O'Fallon WM, Kurland LT. Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain. 1994 Apr;117 ( Pt 2):325-35. doi: 10.1093/brain/117.2.325.

    PubMed 8186959

Questions about this trial

What is this clinical trial studying?

An observational study of Cervical Radicular Pain and Spondylosis, Cervical, run by University Hospital of North Norway at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

patient reported improvement of paresis (complete) (time frame: 12 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07825545, which also lists 12 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in